FDA staff ques­tion ef­fi­ca­cy of Ot­suka's Rex­ul­ti com­bo for PTSD ahead of ad­comm

The FDA is ques­tion­ing whether Ot­su­ka’s Rex­ul­ti in com­bi­na­tion with the an­ti­de­pres­sant Zoloft has enough ef­fi­ca­cy da­ta to back an ap­proval as a new treat­ment …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER